Pfizer Inc Cdr Stock Performance
| PFE Stock | 11.88 0.13 1.08% |
The company holds a Beta of 0.27, which implies not very significant fluctuations relative to the market. As returns on the market increase, Pfizer's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pfizer is expected to be smaller as well. At this point, Pfizer Inc CDR has a negative expected return of -0.14%. Please make sure to check Pfizer's potential upside, daily balance of power, and the relationship between the maximum drawdown and kurtosis , to decide if Pfizer Inc CDR performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
Forward Dividend Yield 0.0645 | Payout Ratio 2.2343 | Forward Dividend Rate 0.79 | Ex Dividend Date 2024-11-08 |
1 | Sanofi Negotiating Exclusively With CDR for Opella 50 percent Stake Sale - Nasdaq | 10/21/2024 |
| Begin Period Cash Flow | 1.3 B |
Pfizer |
Pfizer Relative Risk vs. Return Landscape
If you would invest 1,304 in Pfizer Inc CDR on September 4, 2024 and sell it today you would lose (116.00) from holding Pfizer Inc CDR or give up 8.9% of portfolio value over 90 days. Pfizer Inc CDR is generating negative expected returns and assumes 1.3853% volatility on return distribution over the 90 days horizon. Simply put, 12% of stocks are less volatile than Pfizer, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Pfizer Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pfizer's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pfizer Inc CDR, and traders can use it to determine the average amount a Pfizer's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0982
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PFE |
Estimated Market Risk
| 1.39 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pfizer is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pfizer by adding Pfizer to a well-diversified portfolio.
Pfizer Fundamentals Growth
Pfizer Stock prices reflect investors' perceptions of the future prospects and financial health of Pfizer, and Pfizer fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pfizer Stock performance.
| Return On Equity | 0.0454 | ||||
| Return On Asset | 0.0331 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.33 % | ||||
| Current Valuation | 287.47 B | ||||
| Shares Outstanding | 16.69 B | ||||
| Price To Book | 1.55 X | ||||
| Price To Sales | 3.46 X | ||||
| Revenue | 58.5 B | ||||
| Gross Profit | 66.23 B | ||||
| EBITDA | 18.37 B | ||||
| Net Income | 2.12 B | ||||
| Total Debt | 10.35 B | ||||
| Book Value Per Share | 16.29 X | ||||
| Cash Flow From Operations | 12.04 B | ||||
| Earnings Per Share | 0.36 X | ||||
| Total Asset | 226.5 B | ||||
| Retained Earnings | 118.35 B | ||||
About Pfizer Performance
By examining Pfizer's fundamental ratios, stakeholders can obtain critical insights into Pfizer's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Pfizer is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Pfizer is entity of Canada. It is traded as Stock on NEO exchange.Things to note about Pfizer Inc CDR performance evaluation
Checking the ongoing alerts about Pfizer for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pfizer Inc CDR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pfizer Inc CDR generated a negative expected return over the last 90 days |
- Analyzing Pfizer's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pfizer's stock is overvalued or undervalued compared to its peers.
- Examining Pfizer's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pfizer's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pfizer's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pfizer's stock. These opinions can provide insight into Pfizer's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Pfizer Stock
Pfizer financial ratios help investors to determine whether Pfizer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pfizer with respect to the benefits of owning Pfizer security.